Aquamarine Financial (Cayman) Ltd — 13F-HR — 2026-06-30
U.S. SEC EDGAR · Published 12 Aug 2026 · Collected 22 Oct 2026
Original SEC XML preserved; count and dollar total reconciled; manager attribution retained · Original document retrieved
PERSON / P114INVESTOR
Guy Spier
Longtime Aquamarine Fund manager and author. His website states that outside capital has been returned and Aquamarine now operates as a family office; historical disclosures retain their original dates.
Biography: www.guyspier.com
READ THIS FIRST ↗
These are disclosures by an associated institution. The person’s name provides context; it does not establish current management, personal ownership or who made the trade.
Comparison unavailable.
Choose one report period to compare it with the preceding quarter.
01 / THE RECORDS34 MATCHING RECORDS
The disclosed positions.
2 record sources ↗| ASSET / SECURITY | REPORTED QUANTITY | REPORTED VALUE / USD | WEIGHT | QUARTERLY ACTIVITY | RECORD TYPE / OWNER | SOURCE |
|---|---|---|---|---|---|---|
| 059460303BANCO BRADESCO S A | 186,948,134shares | $649,020,291Reported market value$3.47 / reported unit (derived) | 35.83%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 059460303BANCO BRADESCO S A | 156,848,134shares | $588,694,950Reported market value$3.75 / reported unit (derived) | 43.11%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 984245100YPF SOCIEDAD ANONIMA | 12,444,948shares | $565,871,786Reported market value$45.47 / reported unit (derived) | 31.24%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 984245100YPF SOCIEDAD ANONIMA | 9,026,675shares | $417,212,919Reported market value$46.22 / reported unit (derived) | 30.55%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 399909100GRUPO FINANCIERO GALICIA S.A | 3,515,564shares | $175,883,667Reported market value$50.03 / reported unit (derived) | 9.71%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| G6683N103NU HLDGS LTD | 8,977,636shares | $119,941,217Reported market value$13.36 / reported unit (derived) | 6.62%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 399909100GRUPO FINANCIERO GALICIA S.A | 2,360,982shares | $110,659,144Reported market value$46.87 / reported unit (derived) | 8.10%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 05961W105BANCO MACRO S A | 842,490shares | $78,006,149Reported market value$92.59 / reported unit (derived) | 4.31%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 373737105GERDAU SA | 16,726,171shares | $67,573,731Reported market value$4.04 / reported unit (derived) | 3.73%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 373737105GERDAU SA | 16,726,171shares | $60,381,477Reported market value$3.61 / reported unit (derived) | 4.42%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 05967A107BANCO SANTANDER BRASIL S A | 9,817,925shares | $58,220,295Reported market value$5.93 / reported unit (derived) | 4.26%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 05967A107BANCO SANTANDER BRASIL S A | 10,394,184shares | $54,569,466Reported market value$5.25 / reported unit (derived) | 3.01%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 05961W105BANCO MACRO SA | 532,490shares | $41,198,751Reported market value$77.37 / reported unit (derived) | 3.02%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 058934100BANCO BBVA ARGENTINA S A | 1,701,078shares | $33,358,140Reported market value$19.61 / reported unit (derived) | 1.84%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M7S64L123PAGAYA TECHNOLOGIES LTD | 1,771,209shares | $32,324,564Reported market value$18.25 / reported unit (derived) | 1.78%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 74347Y797PROSHARES TR II | 3,400,000shares | $28,288,000Reported market value$8.32 / reported unit (derived) | 2.07%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 058934100BANCO BBVA ARGENTINA S A | 1,235,322shares | $19,839,271Reported market value$16.06 / reported unit (derived) | 1.45%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| G6683N103NU HLDGS LTD | 1,000,000shares | $14,370,000Reported market value$14.37 / reported unit (derived) | 1.05%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 68403P203ORAMED PHARMACEUTICALS INC | 2,512,175shares | $12,083,562Reported market value$4.81 / reported unit (derived) | 0.67%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M0740A108ALPHA TAU MEDICAL LTD | 721,501shares | $9,076,483Reported market value$12.58 / reported unit (derived) | 0.50%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 22113B103COSAN S A | 2,096,904shares | $8,639,244Reported market value$4.12 / reported unit (derived) | 0.63%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 68403P203ORAMED PHARMACEUTICALS INC | 2,112,312shares | $7,181,861Reported market value$3.4 / reported unit (derived) | 0.53%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 22113B103COSAN S A | 2,096,904shares | $6,039,084Reported market value$2.88 / reported unit (derived) | 0.33%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M0740A108ALPHA TAU MEDICAL LTD | 721,501shares | $5,101,012Reported market value$7.07 / reported unit (derived) | 0.37%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M5R635108INNOVIZ TECHNOLOGIES LTD | 5,828,949shares | $4,436,996Reported market value$0.76 / reported unit (derived) | 0.24%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M5R635108INNOVIZ TECHNOLOGIES LTD | 5,177,278shares | $3,274,628Reported market value$0.63 / reported unit (derived) | 0.24%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M8S7C5117PULSENMORE LTD | 338,541shares | $1,951,897Reported market value$5.77 / reported unit (derived) | 0.11%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M8S7C5117PULSENMORE LTD | 338,541shares | $1,178,714Reported market value$3.48 / reported unit (derived) | 0.09%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 893870204TRANSPORTADORA DE GAS DEL SU | 29,696shares | $1,027,779Reported market value$34.61 / reported unit (derived) | 0.08%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 893870204TRANSPORTADORA DE GAS DEL SU | 29,696shares | $882,862Reported market value$29.73 / reported unit (derived) | 0.05%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 155038201CENTRAL PUERTO S A | 19,314shares | $325,055Reported market value$16.83 / reported unit (derived) | 0.02%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| 155038201CENTRAL PUERTO S A | 19,314shares | $287,006Reported market value$14.86 / reported unit (derived) | 0.02%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M9607U107VALENS SEMICONDUCTOR LTD | 559,653shares | $15,670Reported market value$0.03 / reported unit (derived) | 0.00%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution30 Jun 2026 | U.S. SEC EDGAR ↗Record details ↗ |
| M9607U107VALENS SEMICONDUCTOR LTD | 559,653shares | $14,551Reported market value$0.03 / reported unit (derived) | 0.00%Share of this filing table | No comparable prior disclosure | Quarter-end positionAssociated institution31 Mar 2026 | U.S. SEC EDGAR ↗Record details ↗ |
Figures retain their source’s meaning. Unknown is not zero. Dates, share classes and option exposures may differ; source-table coverage is not a complete personal portfolio.
02 / THE REFERENCES
Go back to the evidence.
Details ↗Open in the source library ↗
Aquamarine Financial (Cayman) Ltd — 13F-HR — 2026-03-31
U.S. SEC EDGAR · Published 15 May 2026 · Collected 22 Oct 2026
Original SEC XML preserved; count and dollar total reconciled; manager attribution retained · Original document retrieved
Found a missing detail or an error?Help improve this record ↗
BUILT WITH YOUR INPUTYour comments help
Your comments help
HoldingsAtlas grow.
Tell us what is useful, what is missing and what we could do better. Your feedback matters.
Visit the feedback page ↗